Randomized Trial of a Novel CMV Vaccine (CMVPepVax) after Allogeneic HCT: Elevated CMV-Specific Immune Response, Reduction in Chronic GvHD and CMV Reactivation Only in Vaccine Arm Patients

Autor: Nakamura, Ryotaro, La Rosa, Corinna *, Longmate, Jeff *, O’Donnell, Margaret *, Cai, Ji-Lian *, Farol, Len *, Salhotra, Amandeep, Snyder, David S, Drake, Jennifer *, Slape, Cynthia *, Merson, James *, Zaia, John A *, Forman, Stephen J., Diamond, Don J.
Zdroj: In Blood 6 December 2014 124(21):183-183
Databáze: ScienceDirect